Cough of cardiovascular origin (Cardiac cough)
Specialty: Cardiovascular.
Why it occurs
- Interstitial pulmonary edema due to acute or chronic left ventricular failure
- Narrow mitral stenosis with pulmonary venocapillary hypertension
- Cough secondary to the use of ACEI drugs (cough due to accumulation of bradykinins in the airway)
- Congestive heart failure with reflex bronchospasm (cardiac asthma)
- Aortic arch aneurysm with compression of the recurrent laryngeal nerve or left main bronchus
Initial workup
Determination of serum B-type natriuretic peptide (BNP) or NT-proBNP; Transthoracic Doppler echocardiogram to evaluate left ventricular systolic function, left atrial size, evaluate mitral/aortic valve disease, and estimate left ventricular diastolic pressure; Chest x-ray in posteroanterior and lateral projections to detect signs of alveolar or interstitial fluid congestion, cephalization of flows and cissural effusion; Spirometry if differential diagnosis with asthma or COPD is required.
red flags
Dry and persistent cough, predominantly at night or when adopting the supine position, which progresses to a productive cough with salmon-colored (pink) and frothy sputum, associated with audible wheezing, orthopnea, paroxysmal nocturnal dyspnea, bilateral wet crackles on pulmonary auscultation, or a sensation of imminent suffocation. These symptoms are characteristic of acute pulmonary edema and require emergency intervention with ventilatory support and intravenous diuretics.
Standard management
- Furosemide — first choice loop diuretic for the management of volume overload and pulmonary venocapillary hypertension; 40 mg intravenous initial bolus, repeatable according to fluid balance
- Losartan — angiotensin II receptor antagonist indicated if the cough is secondary to the use of ACE inhibitors, allowing neurohormonal blockade to be maintained without inducing bradykinin accumulation; 50 to 100 mg once daily orally
- Carvedilol — beta blocker indicated in stable chronic heart failure once the acute condition has been overcome; starting with 3,125 mg twice daily with progressive titration
- Empagliflozin (SGLT2i indicated in systolic or diastolic heart failure to reduce extracellular volume; 10 mg once daily orally).
Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.
- Area
- Cardiovascular
- Listed causes
- 5
- Treatment options
- 4